Evidence map›Paper›PMID 41626211›Full record

ArticleOncology issues2022

How Do You DISCO? Leveraging the Discussions of Cost App to Reduce Financial Toxicity and Improve Treatment Cost Communication.

Lauren M Hamel, David W Dougherty, Lorna Mabunda, Eyouab Tadesse, Raeann Hill, Sanjna Ghanshani, Susan Eggly

Abstract read
In one paragraph

Article in Oncology issues, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lauren M HamelLauren M. Hamel, PhD, is associate professor of oncology and population studies and disparities research co-program leader; Susan Eggly, PhD, is professor of oncology; and Lorna Mabunda, MSI, is project director at Wayne State University School of Medicine, Karmanos Cancer Institute in Detroit, Mich. David W. Dougherty, MD, MBA, is network medical director at the Dana-Farber Cancer Institute in Boston, Mass. Eyouab Tadesse, RaeAnn Hill, and Sanjna Ghanshani are medical students at Wayne State University School of Medicine, Detroit, Mich.
David W DoughertyLauren M. Hamel, PhD, is associate professor of oncology and population studies and disparities research co-program leader; Susan Eggly, PhD, is professor of oncology; and Lorna Mabunda, MSI, is project director at Wayne State University School of Medicine, Karmanos Cancer Institute in Detroit, Mich. David W. Dougherty, MD, MBA, is network medical director at the Dana-Farber Cancer Institute in Boston, Mass. Eyouab Tadesse, RaeAnn Hill, and Sanjna Ghanshani are medical students at Wayne State University School of Medicine, Detroit, Mich.
Lorna MabundaLauren M. Hamel, PhD, is associate professor of oncology and population studies and disparities research co-program leader; Susan Eggly, PhD, is professor of oncology; and Lorna Mabunda, MSI, is project director at Wayne State University School of Medicine, Karmanos Cancer Institute in Detroit, Mich. David W. Dougherty, MD, MBA, is network medical director at the Dana-Farber Cancer Institute in Boston, Mass. Eyouab Tadesse, RaeAnn Hill, and Sanjna Ghanshani are medical students at Wayne State University School of Medicine, Detroit, Mich.
Eyouab TadesseLauren M. Hamel, PhD, is associate professor of oncology and population studies and disparities research co-program leader; Susan Eggly, PhD, is professor of oncology; and Lorna Mabunda, MSI, is project director at Wayne State University School of Medicine, Karmanos Cancer Institute in Detroit, Mich. David W. Dougherty, MD, MBA, is network medical director at the Dana-Farber Cancer Institute in Boston, Mass. Eyouab Tadesse, RaeAnn Hill, and Sanjna Ghanshani are medical students at Wayne State University School of Medicine, Detroit, Mich.
Raeann HillLauren M. Hamel, PhD, is associate professor of oncology and population studies and disparities research co-program leader; Susan Eggly, PhD, is professor of oncology; and Lorna Mabunda, MSI, is project director at Wayne State University School of Medicine, Karmanos Cancer Institute in Detroit, Mich. David W. Dougherty, MD, MBA, is network medical director at the Dana-Farber Cancer Institute in Boston, Mass. Eyouab Tadesse, RaeAnn Hill, and Sanjna Ghanshani are medical students at Wayne State University School of Medicine, Detroit, Mich.
Sanjna GhanshaniLauren M. Hamel, PhD, is associate professor of oncology and population studies and disparities research co-program leader; Susan Eggly, PhD, is professor of oncology; and Lorna Mabunda, MSI, is project director at Wayne State University School of Medicine, Karmanos Cancer Institute in Detroit, Mich. David W. Dougherty, MD, MBA, is network medical director at the Dana-Farber Cancer Institute in Boston, Mass. Eyouab Tadesse, RaeAnn Hill, and Sanjna Ghanshani are medical students at Wayne State University School of Medicine, Detroit, Mich.
Susan EgglyLauren M. Hamel, PhD, is associate professor of oncology and population studies and disparities research co-program leader; Susan Eggly, PhD, is professor of oncology; and Lorna Mabunda, MSI, is project director at Wayne State University School of Medicine, Karmanos Cancer Institute in Detroit, Mich. David W. Dougherty, MD, MBA, is network medical director at the Dana-Farber Cancer Institute in Boston, Mass. Eyouab Tadesse, RaeAnn Hill, and Sanjna Ghanshani are medical students at Wayne State University School of Medicine, Detroit, Mich.

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
NCI NIH HHS P30 CA012197NCI NIH HHS P30 CA022453
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41626211
PMCPMC12857906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.